
Aquaculture Healthcare Market Size By Product (Drug {Parasiticides, Anti-inflammatory, Anti-infectives}, Vaccines {Modified Live Vaccines (MLV), Killed Inactivated Vaccines}, Medicated Feed Additives {Antibiotics, Vitamins, Amino Acids, Enzymes, Antioxida
Description
Aquaculture Healthcare Market Size By Product (Drug {Parasiticides, Anti-inflammatory, Anti-infectives}, Vaccines {Modified Live Vaccines (MLV), Killed Inactivated Vaccines}, Medicated Feed Additives {Antibiotics, Vitamins, Amino Acids, Enzymes, Antioxidants, Prebiotics and Probiotics, Minerals, Hormones}), By Species (Fish {Freshwater Species [Tilapia, Carp], Marine Species [Sea Bass, Sea Bream, Turbot], Diadromous Species [Salmon, Trout]}, Crustaceans {Prawns, Shrimps}), By Infections (Bacterial Infections, Viral Infections, Parasitic Infections, Fungal Infections) By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Distributors, Online Stores, Retail/Aqua Stores), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
Aquaculture Healthcare Market share is expected to grow exponentially by 2032, owing to the rising efforts made by the key players in R&D to offer innovative therapeutic solutions. In addition, aquaculture is one of the fastest-growing forms of food production in the world and the fastest-growing sector in the livestock industry, which is expected to add impetus to the market expansion through 2032.
The companies operating in the aquaculture healthcare market are working on solidifying their revenue generation by providing novel products and solutions, alongside engaging in partnerships, acquisitions, and mergers. For instance, in 2022, Benchmark’s Advanced Nutrition business, INVE Aquaculture, joined the SSP (Sustainable Shrimp Partnership), an initiative built to revolutionize the future of shrimp aquaculture.
Overall, the market is classified in terms of product, species, infection, route of administration, distribution channel, and region.
Considering the product, the drugs segment was valued over USD 487 million in 2022 and is expected to maintain constant growth over the forecast period. The growing concerns around parasites in aquaculture is projected to have an impeccable impact on the demand for healthcare drugs for aquaculture species. Furthermore, the increased outbreak of infectious diseases in aquaculture have resulted in development of several chemical treatments and drugs, which are expected to pave the way for segmental expansion over the next few years.
Based on species, the others segment is expected to register a valuation of over USD 39 million by 2032 end. The other segment consists of molluscs, which plays a crucial role in the human lives. They are sources of jewelry and food and are used as bioindicators in marine and freshwater environments, thus driving the market growth.
By infection, the fungal infection segment is slated to depict an 8% CAGR between 2023 and 2032, owing to the rising prevalence of fungal diseases in aquatic animals. As per credible sources, fungal infections may cause a mortality rate of upto 80-100% in fishes.
In terms of route of administration, the oral segment is expected to register considerable gains during 2023-2032, owing to several benefits such as easy application and saving effort and time. Besides, the rising demand for medicated feed additives that need oral administration is further slated to bolster the market demand through 2032.
Based on the distribution channel, the distributors segment is envisioned to expand profusely through 2032, owing to the vast array of the partner network established by key players in the industry via strategic initiatives including acquisitions and mergers.
In the regional context, the North America aquaculture healthcare market held over 10% market share in 2022 and is anticipated to grow substantially over the forecast period. The growth is attributable to the rising investments made by key players in the R&D process for developing innovative drugs and medications. For instance, in 2019, Merck Animal Health acquired Vaki to enhance its leadership in aquaculture for advancing fish health and welfare.
Aquaculture Healthcare Market share is expected to grow exponentially by 2032, owing to the rising efforts made by the key players in R&D to offer innovative therapeutic solutions. In addition, aquaculture is one of the fastest-growing forms of food production in the world and the fastest-growing sector in the livestock industry, which is expected to add impetus to the market expansion through 2032.
The companies operating in the aquaculture healthcare market are working on solidifying their revenue generation by providing novel products and solutions, alongside engaging in partnerships, acquisitions, and mergers. For instance, in 2022, Benchmark’s Advanced Nutrition business, INVE Aquaculture, joined the SSP (Sustainable Shrimp Partnership), an initiative built to revolutionize the future of shrimp aquaculture.
Overall, the market is classified in terms of product, species, infection, route of administration, distribution channel, and region.
Considering the product, the drugs segment was valued over USD 487 million in 2022 and is expected to maintain constant growth over the forecast period. The growing concerns around parasites in aquaculture is projected to have an impeccable impact on the demand for healthcare drugs for aquaculture species. Furthermore, the increased outbreak of infectious diseases in aquaculture have resulted in development of several chemical treatments and drugs, which are expected to pave the way for segmental expansion over the next few years.
Based on species, the others segment is expected to register a valuation of over USD 39 million by 2032 end. The other segment consists of molluscs, which plays a crucial role in the human lives. They are sources of jewelry and food and are used as bioindicators in marine and freshwater environments, thus driving the market growth.
By infection, the fungal infection segment is slated to depict an 8% CAGR between 2023 and 2032, owing to the rising prevalence of fungal diseases in aquatic animals. As per credible sources, fungal infections may cause a mortality rate of upto 80-100% in fishes.
In terms of route of administration, the oral segment is expected to register considerable gains during 2023-2032, owing to several benefits such as easy application and saving effort and time. Besides, the rising demand for medicated feed additives that need oral administration is further slated to bolster the market demand through 2032.
Based on the distribution channel, the distributors segment is envisioned to expand profusely through 2032, owing to the vast array of the partner network established by key players in the industry via strategic initiatives including acquisitions and mergers.
In the regional context, the North America aquaculture healthcare market held over 10% market share in 2022 and is anticipated to grow substantially over the forecast period. The growth is attributable to the rising investments made by key players in the R&D process for developing innovative drugs and medications. For instance, in 2019, Merck Animal Health acquired Vaki to enhance its leadership in aquaculture for advancing fish health and welfare.
Table of Contents
420 Pages
- Chapter 1 Methodology & Scope
- 1.1 Methodology
- 1.2 Base estimates & calculations
- 1.3 Forecast parameters
- 1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
- 1.4.2.1 Paid sources
- 1.4.2.2 Public sources
- Chapter 2 Executive Summary
- 2.1 Aquaculture healthcare industry 360 degree synopsis, 2018-2032
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Species trends
- 2.1.4 Infection trends
- 2.1.5 Route of administration trends
- 2.1.6 Distribution channel trends
- 2.1.7 Regional trends
- Chapter 3 Aquaculture Healthcare Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 I Increasing demand for fish protein across the world
- 3.2.1.2 Growing incidence of diseases and parasites in farmed fish
- 3.2.1.3 Growing R&D efforts by key market players to bring new solutions for aquaculture healthcare
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Aversion to farmed fish due to health concerns
- 3.2.2.2 Lack of knowledge regarding diseases in aquatic animals
- 3.2.2.3 Concerns over growing antibiotic resistance due to widespread use
- 3.3 Growth potential analysis
- 3.4 COVID-19 impact analysis
- 3.5 Regulatory scenario
- 3.6 Porter’s analysis
- 3.6.1 Bargaining Power of Suppliers
- 3.6.2 Bargaining Power Buyers
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.7 PESTEL analysis
- Chapter 4 Competitive Landscape, 2021
- 4.1 Introduction
- 4.2 Company market share, 2021
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategic outlook matrix
- Chapter 5 Aquaculture Healthcare Market, By Product
- 5.1 Key segment trends
- 5.2 Drugs
- 5.2.1 Market size, by region, 2018-2032 (USD Million)
- 5.2.2 Parasiticides
- 5.2.2.1 Market size, by region, 2018-2032 (USD Million)
- 5.2.3 Anti-inflammatory
- 5.2.3.1 Market size, by region, 2018-2032 (USD Million)
- 5.2.4 Anti-infectives
- 5.2.4.1 Market size, by region, 2018-2032 (USD Million)
- 5.2.5 Others
- 5.2.5.1 Market size, by region, 2018-2032 (USD Million)
- 5.3 Vaccines
- 5.3.1 Market size, by region, 2018-2032 (USD Million)
- 5.3.2 Modified live vaccines [MLV]
- 5.3.2.1 Market size, by region, 2018-2032 (USD Million)
- 5.3.3 Killed inactivated vaccines
- 5.3.3.1 Market size, by region, 2018-2032 (USD Million)
- 5.3.4 Others
- 5.3.4.1 Market size, by region, 2018-2032 (USD Million)
- 5.4 Feed additives
- 5.4.1 Market size, by region, 2018-2032 (USD Million)
- 5.4.2 Antibiotics
- 5.4.2.1 Market size, by region, 2018-2032 (USD Million)
- 5.4.3 Vitamins
- 5.4.3.1 Market size, by region, 2018-2032 (USD Million)
- 5.4.4 Amino acids
- 5.4.4.1 Market size, by region, 2018-2032 (USD Million)
- 5.4.5 Enzymes
- 5.4.5.1 Market size, by region, 2018-2032 (USD Million)
- 5.4.6 Antioxidants
- 5.4.6.1 Market size, by region, 2018-2032 (USD Million)
- 5.4.7 Prebiotics and probiotics
- 5.4.7.1 Market size, by region, 2018-2032 (USD Million)
- 5.4.8 Minerals
- 5.4.8.1 Market size, by region, 2018-2032 (USD Million)
- 5.4.9 Hormones
- 5.4.9.1 Market size, by region, 2018-2032 (USD Million)
- 5.4.10 Others
- 5.4.10.1 Market size, by region, 2018-2032 (USD Million)
- Chapter 6 Aquaculture Healthcare Market, By Species
- 6.1 Key segment trends
- 6.2 Fishes
- 6.2.1 Market size, by region, 2018-2032 (USD Million)
- 6.2.2 Freshwater species
- 6.2.2.1 Market size, by region, 2018-2032 (USD Million)
- 6.2.2.2 Tilapia
- 6.2.2.2.1 Market size, by region, 2018-2032 (USD Million)
- 6.2.2.3 Carps
- 6.2.2.3.1 Market size, by region, 2018-2032 (USD Million)
- 6.2.2.4 Others
- 6.2.2.4.1 Market size, by region, 2018-2032 (USD Million)
- 6.2.3 Marine species
- 6.2.3.1 Market size, by region, 2018-2032 (USD Million)
- 6.2.3.2 Seabass seabream
- 6.2.3.2.1 Market size, by region, 2018-2032 (USD Million)
- 6.2.3.3 Turbot
- 6.2.3.3.1 Market size, by region, 2018-2032 (USD Million)
- 6.2.3.4 Others
- 6.2.3.4.1 Market size, by region, 2018-2032 (USD Million)
- 6.2.4 Diadromous species
- 6.2.4.1 Market size, by region, 2018-2032 (USD Million)
- 6.2.4.2 Salmon
- 6.2.4.2.1 Market size, by region, 2018-2032 (USD Million)
- 6.2.4.3 Trout
- 6.2.4.3.1 Market size, by region, 2018-2032 (USD Million)
- 6.2.4.4 Others
- 6.2.4.4.1 Market size, by region, 2018-2032 (USD Million)
- 6.3 Crustaceans
- 6.3.1 Market size, by region, 2018-2032 (USD Million)
- 6.3.2 Prawns
- 6.3.2.1 Market size, by region, 2018-2032 (USD Million)
- 6.3.3 Shrimps
- 6.3.3.1 Market size, by region, 2018-2032 (USD Million)
- 6.3.4 Others
- 6.3.4.1 Market size, by region, 2018-2032 (USD Million)
- 6.4 Others
- 6.4.1 Market size, by region, 2018-2032 (USD Million)
- Chapter 7 Aquaculture Healthcare Market, By Infection
- 7.1 Key segment trends
- 7.2 Bacterial infection
- 7.2.1 Market size, by region, 2018-2032 (USD Million)
- 7.3 Viral infection
- 7.3.1 Market size, by region, 2018-2032 (USD Million)
- 7.4 Parasitic infection
- 7.4.1 Market size, by region, 2018-2032 (USD Million)
- 7.5 Fungal infection
- 7.5.1 Market size, by region, 2018-2032 (USD Million)
- Chapter 8 Aquaculture Healthcare Market, By Route of Administration
- 8.1 Key segment trends
- 8.2 Oral
- 8.2.1 Market size, by region, 2018-2032 (USD Million)
- 8.3 Injectable
- 8.3.1 Market size, by region, 2018-2032 (USD Million)
- 8.4 Topical
- 8.4.1 Market size, by region, 2018-2032 (USD Million)
- Chapter 9 Aquaculture Healthcare Market, By Distribution Channel
- 9.1 Key segment trends
- 9.2 Distributors
- 9.2.1 Market size, by region, 2018-2032 (USD Million)
- 9.3 Online stores
- 9.3.1 Market size, by region, 2018-2032 (USD Million)
- 9.4 Retail/Aqua stores
- 9.4.1 Market size, by region, 2018-2032 (USD Million)
- 9.5 Others
- 9.5.1 Market size, by region, 2018-2032 (USD Million)
- Chapter 10 Aquaculture Healthcare Market, By Region
- 10.1 Key regional trends
- 10.2 North America
- 10.2.1 Market size, by country, 2018-2032 (USD Million)
- 10.2.2 Market size, by product, 2018-2032 (USD Million)
- 10.2.2.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.2.2.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.2.2.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.2.3 Market size, by species, 2018-2032 (USD Million)
- 10.2.3.1 Market size, by fishes, 2018-2032 (USD Million)
- 10.2.3.1.1 Market size, by freshwater species, 2018-2032 (USD Million)
- 10.2.3.1.2 Market size, by diadromous species, 2018-2032 (USD Million)
- 10.2.3.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.2.4 Market size, by infection, 2018-2032 (USD Million)
- 10.2.5 Market size, by route of administration, 2018-2032 (USD Million)
- 10.2.6 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.2.7 U.S.
- 10.2.7.1 Market size, by product, 2018-2032 (USD Million)
- 10.2.7.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.2.7.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.2.7.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.2.7.2 Market size, by species, 2018-2032 (USD Million)
- 10.2.7.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.2.7.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.2.7.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.2.7.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.2.7.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.2.7.3 Market size, by infection, 2018-2032 (USD Million)
- 10.2.7.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.2.7.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.2.8 Canada
- 10.2.8.1 Market size, by product, 2018-2032 (USD Million)
- 10.2.8.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.2.8.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.2.8.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.2.8.2 Market size, by species, 2018-2032 (USD Million)
- 10.2.8.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.2.8.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.2.8.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.2.8.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.2.8.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.2.8.3 Market size, by infection, 2018-2032 (USD Million)
- 10.2.8.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.2.8.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.3 Europe
- 10.3.1 Market size, by country, 2018-2032 (USD Million)
- 10.3.2 Market size, by product, 2018-2032 (USD Million)
- 10.3.2.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.3.2.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.3.2.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.3.3 Market size, by species, 2018-2032 (USD Million)
- 10.3.3.1 Market size, by fishes, 2018-2032 (USD Million)
- 10.3.3.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.3.3.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.3.3.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.3.4 Market size, by infection, 2018-2032 (USD Million)
- 10.3.5 Market size, by route of administration, 2018-2032 (USD Million)
- 10.3.6 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.3.7 Germany
- 10.3.7.1 Market size, by product, 2018-2032 (USD Million)
- 10.3.7.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.3.7.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.3.7.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.3.7.2 Market size, by species, 2018-2032 (USD Million)
- 10.3.7.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.3.7.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.3.7.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.3.7.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.3.7.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.3.7.3 Market size, by infection, 2018-2032 (USD Million)
- 10.3.7.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.3.7.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.3.8 UK
- 10.3.8.1 Market size, by product, 2018-2032 (USD Million)
- 10.3.8.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.3.8.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.3.8.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.3.8.2 Market size, by species, 2018-2032 (USD Million)
- 10.3.8.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.3.8.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.3.8.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.3.8.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.3.8.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.3.8.3 Market size, by infection, 2018-2032 (USD Million)
- 10.3.8.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.3.8.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.3.9 France
- 10.3.9.1 Market size, by product, 2018-2032 (USD Million)
- 10.3.9.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.3.9.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.3.9.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.3.9.2 Market size, by species, 2018-2032 (USD Million)
- 10.3.9.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.3.9.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.3.9.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.3.9.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.3.9.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.3.9.3 Market size, by infection, 2018-2032 (USD Million)
- 10.3.9.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.3.9.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.3.10 Spain
- 10.3.10.1 Market size, by product, 2018-2032 (USD Million)
- 10.3.10.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.3.10.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.3.10.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.3.10.2 Market size, by species, 2018-2032 (USD Million)
- 10.3.10.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.3.10.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.3.10.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.3.10.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.3.10.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.3.10.3 Market size, by infection, 2018-2032 (USD Million)
- 10.3.10.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.3.10.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.3.11 Italy
- 10.3.11.1 Market size, by product, 2018-2032 (USD Million)
- 10.3.11.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.3.11.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.3.11.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.3.11.2 Market size, by species, 2018-2032 (USD Million)
- 10.3.11.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.3.11.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.3.11.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.3.11.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.3.11.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.3.11.3 Market size, by infection, 2018-2032 (USD Million)
- 10.3.11.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.3.11.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.3.12 Demark
- 10.3.12.1 Market size, by product, 2018-2032 (USD Million)
- 10.3.12.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.3.12.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.3.12.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.3.12.2 Market size, by species, 2018-2032 (USD Million)
- 10.3.12.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.3.12.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.3.12.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.3.12.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.3.12.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.3.12.3 Market size, by infection, 2018-2032 (USD Million)
- 10.3.12.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.3.12.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.3.13 Iceland
- 10.3.13.1 Market size, by product, 2018-2032 (USD Million)
- 10.3.13.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.3.13.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.3.13.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.3.13.2 Market size, by species, 2018-2032 (USD Million)
- 10.3.13.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.3.13.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.3.13.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.3.13.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.3.13.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.3.13.3 Market size, by infection, 2018-2032 (USD Million)
- 10.3.13.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.3.13.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.3.14 Ireland
- 10.3.14.1 Market size, by product, 2018-2032 (USD Million)
- 10.3.14.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.3.14.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.3.14.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.3.14.2 Market size, by species, 2018-2032 (USD Million)
- 10.3.14.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.3.14.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.3.14.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.3.14.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.3.14.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.3.14.3 Market size, by infection, 2018-2032 (USD Million)
- 10.3.14.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.3.14.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.3.15 Norway
- 10.3.15.1 Market size, by product, 2018-2032 (USD Million)
- 10.3.15.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.3.15.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.3.15.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.3.15.2 Market size, by species, 2018-2032 (USD Million)
- 10.3.15.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.3.15.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.3.15.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.3.15.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.3.15.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.3.15.3 Market size, by infection, 2018-2032 (USD Million)
- 10.3.15.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.3.15.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.3.16 Poland
- 10.3.16.1 Market size, by product, 2018-2032 (USD Million)
- 10.3.16.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.3.16.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.3.16.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.3.16.2 Market size, by species, 2018-2032 (USD Million)
- 10.3.16.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.3.16.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.3.16.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.3.16.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.3.16.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.3.16.3 Market size, by infection, 2018-2032 (USD Million)
- 10.3.16.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.3.16.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.3.17 Turkey
- 10.3.17.1 Market size, by product, 2018-2032 (USD Million)
- 10.3.17.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.3.17.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.3.17.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.3.17.2 Market size, by species, 2018-2032 (USD Million)
- 10.3.17.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.3.17.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.3.17.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.3.17.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.3.17.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.3.17.3 Market size, by infection, 2018-2032 (USD Million)
- 10.3.17.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.3.17.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.4 Asia Pacific
- 10.4.1 Market size, by country, 2018-2032 (USD Million)
- 10.4.2 Market size, by product, 2018-2032 (USD Million)
- 10.4.2.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.4.2.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.4.2.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.4.3 Market size, by species, 2018-2032 (USD Million)
- 10.4.3.1 Market size, by fishes, 2018-2032 (USD Million)
- 10.4.3.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.4.3.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.4.3.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.4.3.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.4.4 Market size, by infection, 2018-2032 (USD Million)
- 10.4.5 Market size, by route of administration, 2018-2032 (USD Million)
- 10.4.6 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.4.7 China
- 10.4.7.1 Market size, by product, 2018-2032 (USD Million)
- 10.4.7.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.4.7.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.4.7.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.4.7.2 Market size, by species, 2018-2032 (USD Million)
- 10.4.7.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.4.7.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.4.7.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.4.7.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.4.7.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.4.7.3 Market size, by infection, 2018-2032 (USD Million)
- 10.4.7.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.4.7.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.4.8 Vietnam
- 10.4.8.1 Market size, by product, 2018-2032 (USD Million)
- 10.4.8.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.4.8.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.4.8.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.4.8.2 Market size, by species, 2018-2032 (USD Million)
- 10.4.8.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.4.8.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.4.8.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.4.8.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.4.8.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.4.8.3 Market size, by infection, 2018-2032 (USD Million)
- 10.4.8.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.4.8.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.4.9 Indonesia
- 10.4.9.1 Market size, by product, 2018-2032 (USD Million)
- 10.4.9.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.4.9.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.4.9.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.4.9.2 Market size, by species, 2018-2032 (USD Million)
- 10.4.9.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.4.9.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.4.9.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.4.9.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.4.9.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.4.9.3 Market size, by infection, 2018-2032 (USD Million)
- 10.4.9.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.4.9.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.4.10 India
- 10.4.10.1 Market size, by product, 2018-2032 (USD Million)
- 10.4.10.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.4.10.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.4.10.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.4.10.2 Market size, by species, 2018-2032 (USD Million)
- 10.4.10.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.4.10.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.4.10.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.4.10.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.4.10.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.4.10.3 Market size, by infection, 2018-2032 (USD Million)
- 10.4.10.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.4.10.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.4.11 Thailand
- 10.4.11.1 Market size, by product, 2018-2032 (USD Million)
- 10.4.11.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.4.11.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.4.11.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.4.11.2 Market size, by species, 2018-2032 (USD Million)
- 10.4.11.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.4.11.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.4.11.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.4.11.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.4.11.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.4.11.3 Market size, by infection, 2018-2032 (USD Million)
- 10.4.11.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.4.11.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.4.12 Bangladesh
- 10.4.12.1 Market size, by product, 2018-2032 (USD Million)
- 10.4.12.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.4.12.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.4.12.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.4.12.2 Market size, by species, 2018-2032 (USD Million)
- 10.4.12.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.4.12.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.4.12.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.4.12.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.4.12.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.4.12.3 Market size, by infection, 2018-2032 (USD Million)
- 10.4.12.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.4.12.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.4.13 Philippines
- 10.4.13.1 Market size, by product, 2018-2032 (USD Million)
- 10.4.13.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.4.13.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.4.13.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.4.13.2 Market size, by species, 2018-2032 (USD Million)
- 10.4.13.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.4.13.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.4.13.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.4.13.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.4.13.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.4.13.3 Market size, by infection, 2018-2032 (USD Million)
- 10.4.13.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.4.13.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.4.14 Australia
- 10.4.14.1 Market size, by product, 2018-2032 (USD Million)
- 10.4.14.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.4.14.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.4.14.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.4.14.2 Market size, by species, 2018-2032 (USD Million)
- 10.4.14.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.4.14.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.4.14.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.4.14.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.4.14.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.4.14.3 Market size, by infection, 2018-2032 (USD Million)
- 10.4.14.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.4.14.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.4.15 New Zealand
- 10.4.15.1 Market size, by product, 2018-2032 (USD Million)
- 10.4.15.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.4.15.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.4.15.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.4.15.2 Market size, by species, 2018-2032 (USD Million)
- 10.4.15.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.4.15.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.4.15.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.4.15.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.4.15.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.4.15.3 Market size, by infection, 2018-2032 (USD Million)
- 10.4.15.4 Market size, by route of administration, 2018-2032 (USD Million)
- 10.4.15.5 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.5 Latin America
- 10.5.1 Market size, by country, 2018-2032 (USD Million)
- 10.5.2 Market size, by product, 2018-2032 (USD Million)
- 10.5.2.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.5.2.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.5.2.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.5.3 Market size, by species, 2018-2032 (USD Million)
- 10.5.3.1 Market size, by fishes, 2018-2032 (USD Million)
- 10.5.3.1.1 Market size, by freshwater species, 2018-2032 (USD Million)
- 10.5.3.1.2 Market size, by diadromous species, 2018-2032 (USD Million)
- 10.5.3.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.5.4 Market size, by infection, 2018-2032 (USD Million)
- 10.5.5 Market size, by route of administration, 2018-2032 (USD Million)
- 10.5.6 Market size, by distribution channel, 2018-2032 (USD Million)
- 10.5.7 Brazil
- 10.5.7.1 Market size, by product, 2018-2032 (USD Million)
- 10.5.7.1.1 Market size, by drugs, 2018-2032 (USD Million)
- 10.5.7.1.2 Market size, by vaccines, 2018-2032 (USD Million)
- 10.5.7.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
- 10.5.7.2 Market size, by species, 2018-2032 (USD Million)
- 10.5.7.2.1 Market size, by fish, 2018-2032 (USD Million)
- 10.5.7.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
- 10.5.7.2.1.2 Market size, by marine, 2018-2032 (USD Million)
- 10.5.7.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
- 10.5.7.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
- 10.5.7.3 Market size, by infection, 2018-2032 (USD Million)
- 10.5.7.4 Market size, by route of administration, 2018-2032 (USD Million)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.